Other Initiatives

Other Initiatives

IDSA: Antibiotic Resistance Policy Update

IDSA recently sent an Antibiotic Resistance Policy Update to more than 1,100 staffers on Capital Hill. Included in this document are the following items of interest of PIDS members.

  • In recognition of the imbalance between the dwindling antibiotic pipeline and the significant clinical need for new drugs to treat antibiotic-resistant infections, IDSA and other stakeholders have launched the 10 X '20 Initiative. This is an effort to mobilize key leaders and resources with the goal of creating a Research and Development enterprise powerful enough to produce 10 new antibiotics by the year 2020. The 10 X '20 Initiative statement will appear in the 4/15/10 issue of Clinical Infectious Diseases.
  • IDSA placed an emphasis on drugs for the ESKAPE Pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which effectively and often “escape” currently approved antibacterial drugs. ESKAPE pathogens cause the majority of U.S. health care-associated infections (HAIs).
  • IDSA recommended a combination of incentives for Biopharma and the need to reduce regulatory uncertainties within the FDA IND requirements.
  • Also, as part of a Trans-Atlantic Initiative, IDSA sent a letter to President Obama and Prime Minister Reinfeldt of Sweden, stating a need for a specialized work group to deal with the antibiotic drug pipeline problem. PIDS also sent a letter to Obama and Reinfeldt supporting this initiative.
  • IDSA has prepared a summary of the STAAR Act, background paper, and a Q & A to assist us in review of this critically needed legislation. http://www.idsociety.org/STAARSummary.htm, http://www.idsociety.org/STAARBackgrounder.htm

The use of antibiotics in animals has recently received a lot of press. The New York Times recently published a column by Nicholas Kristoff while the Miami Herald and several other newspapers around the country carried an op-ed piece by IDSA President Rich Whitley. (March 2010)

Website developed by Katalyst Solutions, LLC